Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?

dc.creatorTendler, Miriam
dc.creatorVilar, Monica Magno
dc.creatorBrito, Cristiana Alves
dc.creatorFreire, Nicolau Maués da Serra
dc.creatorKatz, Naftale
dc.creatorSimpson, Andrew
dc.date2020-09-29T18:26:13Z
dc.date2020-09-29T18:26:13Z
dc.date1995
dc.date.accessioned2023-09-26T22:58:29Z
dc.date.available2023-09-26T22:58:29Z
dc.identifierTENDLER, Miriam et al. Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 90, n. 2, p. 255-256, Mar./Apr. 1995.
dc.identifier0074-0276
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/43691
dc.identifier10.1590/S0074-02761995000200022
dc.identifier1678-8060
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8885396
dc.descriptionMolecular cloning of components of protective antigenic preparations have suggested that related parasite fatty acid binding proteins could form the basis of the well documented protective, immune cross reactivity between the parasitic trematode worms Fasciola hepatica and Schistosoma mansoni. We have now confirmed the cross protective potential of parasite fatty acid binding proteins and suggest that it may be possible to produce a single vaccine that would be effective against at least two parasites, F. hepatica and S. mansoni of veterinary and human importance respectively.
dc.formatapplication/pdf
dc.languageeng
dc.publisherFundação Oswaldo Cruz. Instituto Oswaldo Cruz.
dc.rightsopen access
dc.subjectEsquistossomose
dc.subjectFascioliasis
dc.subjectVacinas
dc.subjectProteína de ligação de ácido graxo
dc.subjectSchistosomiasis
dc.subjectFascioliasis
dc.subjectVaccines
dc.subjectFatty acid binding protein
dc.titleVaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?
dc.typeArticle


Este ítem pertenece a la siguiente institución